How can the resources of the private sector be more effectively leveraged to help battle three of the world’s most devastating communicable diseases? This was the topic on Monday when Patrik Silborn, the head of the Private Sector Engagement Department for the Global Fund to Fight AIDS, Tuberculosis and Malaria, joined in a roundtable discussion in Tokyo, where he presented …
The Japan Center for International Exchange (JCIE) and its Friends of the Global Fund, Japan (FGFJ) initiative, organized a series of events during the Fifth Tokyo International Conference on African Development (TICAD V).
At the G20 Business Summit held in Seoul this week, Takeda Pharmaceutical President and CEO Yasuchika Hasegawa and Anglo American Chief Executive Cynthia Carroll co-convened a working group meeting on access to healthcare.
On March 18, 2010, Takeda Pharmaceutical and the Global Fund announced an exciting new partnership in which Takeda will contribute JPY1 billion (approximately US$10 million) over ten years for the Global Fund’s programs.
A number of corporations have launched innovative and effective programs to help combat these diseases, and their experiences were explored in a half-day symposium on June 28, 2005, that brought together leaders from the corporate, nonprofit, philanthropic, and governmental sectors in Japan and around the world.